TrialInvestigational new drugs2012
Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients.
Maria Cristina Villarroel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papertrialcites it